Factors Associated With Length of Stay and 30-Day Revisits in Pediatric Acute Pancreatitis

Journal of Pediatric Gastroenterology and Nutrition
Anna C GayChristopher J Russell

Abstract

The objective of the study was to identify factors associated with length of stay (LOS) and 30-day hospital revisit for patients hospitalized with acute pancreatitis (AP). Multicenter, retrospective cohort study using the Pediatric Health Information System database. Multilevel linear and logistic regression was used to identify factors independently associated with the primary outcome variables of LOS and 30-day hospital revisit in children aged 1 and 18 years discharged with a primary discharge diagnosis of AP from participating hospitals between 2008 and 2013. For the 7693 discharges, median LOS was 4 days (interquartile range 3-7 days) and 30-day revisit rate 17.6% (n = 1356). Discharges were primarily girls (55%), Caucasian (46%), and 6 years old or older (85%). On multilevel regression, factors independently associated with both longer LOS and higher revisit odds included malignant and gastrointestinal complex chronic conditions (CCCs) and total parenteral nutrition use while hospitalized. Male gender was associated with both lower LOS (adjusted length of stay = -0.6 days, 95% confidence interval [CI] = -0.8 to -0.4) and decreased revisit odds (aOR 0.85; 95% CI = 0.74 to 0.97). Hispanic ethnicity was associated with incre...Continue Reading

References

Jul 24, 2002·The American Journal of Gastroenterology·John R DeBantoUNKNOWN Midwest Multicenter Pancreatic Study Group
May 11, 2007·Journal of Gastroenterology and Hepatology·Andreas NydeggerMark R Oliver
Dec 25, 2007·The Journal of Pediatrics·Leena Kandula, Mark E Lowe
Jun 9, 2009·Journal of Pediatric Gastroenterology and Nutrition·Alexander ParkSohail Zakiuddin Husain
Jun 30, 2009·Academic Pediatrics·Joseph A SkeltonSarah E Barlow
May 19, 2010·Journal of Pediatric Gastroenterology and Nutrition·Alexander J ParkSohail Z Husain
Feb 22, 2011·Journal of Pediatric Gastroenterology and Nutrition·Harrison X BaiSohail Z Husain
Jun 21, 2011·Journal of Pediatric Surgery·Timothy B LautzJayant Radhakrishnan
Oct 18, 2011·Journal of Pediatric Gastroenterology and Nutrition·Michael H MaSohail Z Husain
Feb 24, 2012·Journal of Pediatric Gastroenterology and Nutrition·Veronique D MorinvilleUNKNOWN INSPPIRE Group
Mar 23, 2012·Journal of Pediatric Gastroenterology and Nutrition·Alexandre FabreJacques Sarles
Jun 19, 2012·Journal of Pediatric Surgery·Timothy B LautzAnthony C Chin
Aug 23, 2012·Pediatric Obesity·M S RendallI Vaynman
Jul 31, 2013·The American Journal of Gastroenterology·Scott TennerUNKNOWN American College of Gastroenterology
Feb 27, 2014·JAMA : the Journal of the American Medical Association·Cynthia L OgdenKatherine M Flegal
Apr 9, 2014·JAMA Pediatrics·Asheley Cockrell Skinner, Joseph A Skelton
Apr 16, 2014·The Pediatric Infectious Disease Journal·JoAnna K LeyenaarPeter K Lindenauer
Sep 22, 2015·Pancreas·Peter J W LeeTyler Stevens
Dec 26, 2015·Journal of Pediatric Gastroenterology and Nutrition·Chaitanya PantMojtaba Olyaee
Feb 14, 2016·Cancer Medicine·Milica StefanovićMatthias Löhr
Oct 27, 2016·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Jessica M GoldJay G Berry
Jun 7, 2017·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Satish MunigalaGuru Trikudanathan
Jul 10, 2017·The Journal of Surgical Research·Faidah BadruGustavo Villalona
Nov 28, 2017·The Journal of Pediatrics·Maisam Abu-El-HaijaDarwin L Conwell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.